# OS Therapies Inc: Form 8-K, filed Aug 6, 2026

- Company: [OS Therapies Inc](/companies/ostx.md) (CIK 1795091)
- Form: 8-K
- Filed: 2026-08-06
- Accepted by EDGAR: Aug 6, 2026, 16:13 ET
- Period: 2026-07-31
- Accession: 0001213900-26-086150
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/ea0300848-8k_ostherapies.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/ea0300848-8k_ostherapies.htm

Filed Aug 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-086150. Last ingested by Listed: Nov 10, 2026, 21:09 ET. No prices; not investment advice.